The Pharmaceutical Potential of α- and β-Amyrins
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
(1) Plant-derived pharmaceuticals represent a highly compelling area of research and continue to attract significant interest from countries, regions, scientific communities, and pharmaceutical companies worldwide. Among these, α- and β-amyrins have been identified as high-value triterpenoid compounds with a broad spectrum of potential therapeutic properties, including anti-inflammatory, anti-diabetic, anti-atherosclerotic, analgesic, anti-gout, neuroprotective, anti-Parkinsonian, anticancer, antibacterial, and anti-HIV activities (2) Methods: Relevant information and data were obtained through comprehensive searches of major scientific databases, including Web of Science, Elsevier, and the National Library of Medicine (3) Results: This study highlighted the pharmaceutical potential of α- and β-amyrins, supported by specific evidence from in vivo, in vitro, and clinical trials. Various extraction methods for α- and β-amyrins have been discussed, followed by recommendations for future directions in the development of these compounds as pharmaceutical agents and functional food ingredients (4) Conclusions: This document served as a vital reference for harnessing the therapeutic potential of α- and β-amyrin compounds in the prevention and treatment of various serious diseases worldwide, potentially opening new opportunities and directions for the pharmaceutical industry.